From the Prodrome to Chronic Schizophrenia: The Neurobiology Underlying Psychotic Symptoms and Cognitive Impairments

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|4|459-465

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.4, 2012-02, pp. : 459-465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lamotrigine: Exacerbation of psychotic symptoms in patients with schizophrenia: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1191, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia

By Moghaddam Bita  

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 39-44

Springer Publishing Company

Access to resources Recommend Favorite

Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer’s Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2064-2071

Bentham Science Publishers

Access to resources Recommend Favorite

Switch from Risperidone to Perospirone in Patients with Chronic Schizophrenia

By Fujita K.  

Clinical Drug Investigation, Vol. 24, Iss. 5, 2004-01 ,pp. : 295-299

Adis International

Access to resources Recommend Favorite

Switch from atypicals to long-acting risperidone improves symptoms in schizophrenia

By  

Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite